Tumour Antigens Blog Post

CancerTools.org is committed to empower cancer researchers and the advancement of novel discoveries in tumour immunology by providing relevant research tools, including antibodies targeting tumour antigens. Image: Human breast cancer stained […]

Tumour Immunology Antibodies Page

Tumour immunology studies the complex interactions between cancer cells and the immune system. Research in this field aims to uncover the mechanisms by which the immune system inhibits cancer growth […]

Lung cancer Page

[…] vivo patient derived xenograft (PDX) to enhance preclinical drug discovery Widely used antibodies to study tumour immunology and signalling. Image: Lung cancer cells under the microscope. provided courtesy of Anne Weston, […]

Breast cancer Page

[…] models to enhance preclinical drug discovery workflows, as well as widely used antibodies to study tumour signalling pathways.   CancerTools.org provides diverse breast cancer cell lines to accurately model the tumour-microenvironment, […]

Introducing the pcPPT-mPGK-attR-sLPmCherry-WPRE vector Blog Post

One of the major challenges for tumour research is identifying how tumour cells exploit their surrounding cells, the so-called tumour microenvironment (TME), to help form and expand the tumour itself. […]

Targeting the difficult-to-drug protein – MYC Blog Post

[…] of cancer and distinct subtypes have been identified. Adding to the challenging complexities of cancer, is tumour heterogeneity, which refers to the differences among tumours of the same type within different […]

Anti-HIF1A [Ha111a] Product

[…] microenvironment or genetic changes, is known to have an important role in the growth of experimental tumours. HIF1A has been observed in varying subsets of tumour cells from various solid tumours.

Anti-Tumor Necrosis Factor (TNF-a) [12F6] Product

Tumor necrosis factor is a cell signaling protein or cytokine that is involved in inflammation, and specifically one of the proteins in the acute phase reaction.

Cell staining with SMP14 hybridoma supernatant of MCF7 treated with Nutlin

Anti-MDM2 [SMP14] Product

MDM2 is over-expressed in many tumours. Its principal function is the ubiquitination and degradation of p53 tumour suppressor protein.